We also treated MEFs with CM from MDA-MB-231 cells and performed western blot analysis with anti-S1P2 antibody in order to establish whether the breast cancer S1P2 receptor is taken up by fibroblasts from CM or exosomes. This evidence concerns the gene S1PR2 and breast carcinoma.